JP2020529395A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020529395A5 JP2020529395A5 JP2019569733A JP2019569733A JP2020529395A5 JP 2020529395 A5 JP2020529395 A5 JP 2020529395A5 JP 2019569733 A JP2019569733 A JP 2019569733A JP 2019569733 A JP2019569733 A JP 2019569733A JP 2020529395 A5 JP2020529395 A5 JP 2020529395A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- zikv
- composition according
- mutation
- genetically engineered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762518300P | 2017-06-12 | 2017-06-12 | |
| US62/518,300 | 2017-06-12 | ||
| US201762574537P | 2017-10-19 | 2017-10-19 | |
| US62/574,537 | 2017-10-19 | ||
| PCT/US2018/036858 WO2018231690A1 (en) | 2017-06-12 | 2018-06-11 | Zika virus strains for treatment of glioblastoma |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020529395A JP2020529395A (ja) | 2020-10-08 |
| JP2020529395A5 true JP2020529395A5 (enExample) | 2021-07-26 |
| JP7525853B2 JP7525853B2 (ja) | 2024-07-31 |
Family
ID=64660846
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019569733A Active JP7525853B2 (ja) | 2017-06-12 | 2018-06-11 | グリオブラストーマを治療するためのジカウイルス株 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12274725B2 (enExample) |
| EP (1) | EP3638304B1 (enExample) |
| JP (1) | JP7525853B2 (enExample) |
| AU (1) | AU2018283957B2 (enExample) |
| CA (1) | CA3067164A1 (enExample) |
| WO (1) | WO2018231690A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3067164A1 (en) | 2017-06-12 | 2018-12-20 | Washington University | Zika virus strains for treatment of glioblastoma |
| US10993975B2 (en) | 2017-08-07 | 2021-05-04 | The Nemours Foundation | Zika virus treatment of CD24-positive tumors and diseases associated with abnormal T cell activation and treating or preventing Zika virus infections |
| US12473570B2 (en) | 2019-05-21 | 2025-11-18 | The Regents Of The University Of California | Zika virus constructs and therapeutic compositions thereof |
| CN113679744B (zh) * | 2020-05-18 | 2023-12-29 | 中国人民解放军军事科学院军事医学研究院 | 寨卡病毒或其与用于免疫检查点治疗的药物在治疗胶质母细胞瘤中的用途 |
| JP7846133B2 (ja) * | 2021-05-04 | 2026-04-14 | アリヴィッド エルエルシー | 脳腫瘍治療のための生物学的実体物 |
| CN119137275A (zh) * | 2022-02-22 | 2024-12-13 | 维罗生物公司 | 溶瘤病毒和使用方法 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4394448A (en) | 1978-02-24 | 1983-07-19 | Szoka Jr Francis C | Method of inserting DNA into living cells |
| US4529561A (en) | 1978-03-24 | 1985-07-16 | The Regents Of The University Of California | Method for producing liposomes in selected size range |
| US4241046A (en) | 1978-11-30 | 1980-12-23 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4925661A (en) | 1984-04-19 | 1990-05-15 | Leaf Huang | Target-specific cytotoxic liposomes |
| US4957735A (en) | 1984-06-12 | 1990-09-18 | The University Of Tennessee Research Corporation | Target-sensitive immunoliposomes- preparation and characterization |
| US4755388A (en) | 1984-11-09 | 1988-07-05 | The Regents Of The University Of California | Liposome-encapsulated 5-fluoropyrimidines and methods for their use |
| DE3542773A1 (de) | 1985-12-04 | 1987-06-11 | Roehm Pharma Gmbh | Hautwirksame pharmaka mit liposomen als wirkstofftraeger |
| US4828837A (en) | 1987-03-30 | 1989-05-09 | Liposome Technology, Inc. | Non-crystalline minoxidil composition, its production and application |
| US5077211A (en) | 1988-07-06 | 1991-12-31 | Applied Genetics, Inc. | Purification and administration of dna repair enzymes |
| US5043164A (en) | 1989-01-17 | 1991-08-27 | The University Of Tennessee Research Corporation | Blood-stable, cholesterol-free liposomes |
| US5064655A (en) | 1989-02-24 | 1991-11-12 | Liposome Technology, Inc. | Liposome gel composition and method |
| US5264618A (en) | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
| EP1861491A4 (en) | 2005-02-16 | 2009-07-08 | Replikun Biotech Pty Ltd | FLAVIVIRUS REPLICON CONSTRUCTS FOR ANTITUMOR THERAPY |
| JP5779352B2 (ja) * | 2008-03-14 | 2015-09-16 | サノフィ パスツール バイオロジクス リミテッド ライアビリティ カンパニー | 複製欠損フラビウイルスワクチンおよびワクチンベクター |
| WO2017004567A1 (en) | 2015-07-02 | 2017-01-05 | PrimeVax Immuno-Oncology, Inc. | Compositions and methods for combination therapy with dengue virus and dendritic cells |
| JP6896700B2 (ja) | 2015-07-16 | 2021-06-30 | バハラ バイオテック インターナショナル リミテッド | ワクチン組成物 |
| US20190202886A1 (en) * | 2016-05-11 | 2019-07-04 | Ohio State Innovation Foundation | ONCOLYTIC VIRUSES COMPRISING esRAGE AND METHODS OF TREATING CANCER |
| US10786537B2 (en) | 2016-08-18 | 2020-09-29 | Cedars-Sinai Medical Center | Method of inducing an oncolytic effect on tumor cells using Zika virus |
| CA3067164A1 (en) | 2017-06-12 | 2018-12-20 | Washington University | Zika virus strains for treatment of glioblastoma |
| US12178869B2 (en) | 2017-12-22 | 2024-12-31 | Codagenix Inc. | Recombinant virus with codon-pair deoptimized region and uses thereof for the treatment of cancer |
-
2018
- 2018-06-11 CA CA3067164A patent/CA3067164A1/en active Pending
- 2018-06-11 AU AU2018283957A patent/AU2018283957B2/en active Active
- 2018-06-11 JP JP2019569733A patent/JP7525853B2/ja active Active
- 2018-06-11 EP EP18818114.3A patent/EP3638304B1/en active Active
- 2018-06-11 US US16/622,180 patent/US12274725B2/en active Active
- 2018-06-11 WO PCT/US2018/036858 patent/WO2018231690A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rodrigues et al. | Pathogenesis of cholangiocarcinoma | |
| JP2019088286A5 (enExample) | ||
| JP2021104038A5 (enExample) | ||
| Welker et al. | Recurrent hepatocellular carcinoma after liver transplantation–an emerging clinical challenge | |
| Han et al. | Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma | |
| CN103402545B (zh) | 疏水性经修饰肽及其在肝特异性靶向中的用途 | |
| JP2010520758A5 (enExample) | ||
| BR112021013876A2 (pt) | Codificação de rhabdovírus recombinante para ccl21 | |
| US20190144833A1 (en) | Genetically stable oncolytic rna virus, method of manufacturing and use thereof | |
| Osugi et al. | Oral fluoropyrimidine anticancer drug TS-1 for gastric cancer patients with peritoneal dissemination | |
| CA2517147A1 (en) | Use of myxoma virus for the therapeutic treatment of cancer and chronic viral infection | |
| Hamid | Epidemiology and outcomes of nasopharyngeal carcinoma | |
| Khawkhiaw et al. | Interleukin-1β: friend or foe for gastrointestinal cancers | |
| BR112021004451A2 (pt) | método para produção de um arenavírus antitumoral, bem como mutantes de arenavírus | |
| Celik et al. | A case with primary signet ring cell adenocarcinoma of the prostate and review of the literature | |
| WO2022001080A1 (zh) | 一种重组单纯疱疹病毒及其构建方法 | |
| WO2020238427A1 (zh) | 特异杀伤肿瘤细胞的溶瘤病毒系统及其应用 | |
| JP2024508823A5 (enExample) | ||
| Qu et al. | Up-regulation of long non-coding RNA MFI2 functions as an oncogenic role in cervical cancer progression. | |
| Patalano et al. | S3739 Acute Liver Failure Due to Metastatic Uveal Melanoma | |
| JP2022539016A5 (enExample) | ||
| EP4556017A1 (en) | Hepatitis b virus receptor oatp and use thereof | |
| Shah | The development of bevacizumab in noncolorectal gastrointestinal malignancies: gastroesophageal, pancreatic, and hepatocellular carcinoma | |
| Agüero et al. | Neuroendocrine tumor and lutetium therapy | |
| CN107970246B (zh) | 非甾体类抗炎药在提高肿瘤细胞对酪氨酸激酶抑制剂的敏感性中的应用 |